Human Immunodeficiency Virus Preexposure Prophylaxis: Meeting the Needs of Transgender Populations

被引：3

作者：

Krakower, Douglas S. ^{[1
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Div Infect Dis, 110 Francis St, Boston, MA 02215 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2021年 / 73卷 / 07期

关键词：

HIV; HIV prevention; preexposure prophylaxis; transgender populations; clinical pharmacology;

D O I：

10.1093/cid/ciaa1158

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：E2124 / E2126

页数：3

共 11 条

[1] Estimating the Prevalence of HIV and Sexual Behaviors Among the US Transgender Population: A Systematic Review and Meta-Analysis, 2006-2017 [J].

Becasen, Jeffrey S. ;

Denard, Christa L. ;

Mullins, Mary M. ;

Higa, Darrel H. ;

Sipe, Theresa Ann .

AMERICAN JOURNAL OF PUBLIC HEALTH, 2019, 109 (01) :E1-E8

[2] Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis [J].

Cottrell, Mackenzie L. ;

Prince, Heather M. A. ;

Schauer, Amanda P. ;

Sykes, Craig ;

Maffuid, Kaitlyn ;

Poliseno, Amanda ;

Chun, Tae-Wook ;

Huiting, Erin ;

Stanczyk, Frank Z. ;

Peery, Anne F. ;

Dellon, Evan S. ;

Adams, Jessica L. ;

Gay, Cindy ;

Kashuba, Angela D. M. .

CLINICAL INFECTIOUS DISEASES, 2019, 69 (12) :2201-2204

[3]

Grinsztejn B, 2020, J INT AIDS SOC, V23, P174

[4] Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study [J].

Hiransuthikul, Akarin ;

Janamnuaysook, Rena ;

Himmad, Kanittha ;

Kerr, Stephen J. ;

Thammajaruk, Narukjaporn ;

Pankam, Tippawan ;

Phanjaroen, Kannapat ;

Mills, Stephen ;

Vannakit, Ravipa ;

Phanuphak, Praphan ;

Phanuphak, Nittaya .

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (07)

[5]

Landovitz RJ, 2020, J INT AIDS SOC, V23, P183

[6]

Mayer KH, 2020, LANCET, V396, P239, DOI 10.1016/S0140-6736(20)31065-5

[7] Strategies for engaging transgender populations in HIV prevention and care [J].

Poteat, Tonia ;

Wirtz, Andrea L. ;

Reisner, Sari .

CURRENT OPINION IN HIV AND AIDS, 2019, 14 (05) :393-400

[8]

Prins M, 2020, C RETROVIRUSES OPPOR

[9] Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men [J].

Shieh, Eugenie ;

Marzinke, Mark A. ;

Fuchs, Edward J. ;

Hamlin, Allyson ;

Bakshi, Rahul ;

Aung, Wutyi ;

Breakey, Jennifer ;

Poteat, Tonia ;

Brown, Todd ;

Bumpus, Namandje N. ;

Hendrix, Craig W. .

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (11)

[10]

White Hughto Jaclyn M, 2016, Transgend Health, V1, P21

← 1 2 →